English  |
| Quantity: | |
|---|---|
CAS 52237-19-1
Langyou
52237-19-1
52237-19-1
Basic Info:
Product: CGP 11130
CAS: 52237-19-1
Form: White Powder
Purity: 99%
MF: C10H12FNO2
MW: 197.21
Package: 1-2kg/Aluminum Foil Bag, 25kg/Drum Factory supply
Sample: Available (Freight need to be paid）
Production Capacity: 200kg/Month
Payment Terms: 100% T/T, Western Union, Money Gram, Bitcoin, Tether, Monero, Bank Transfer
Delivery Time: Ship out immediately once receiving Payment
Note: Guarantee Customs
Synonyms: CGP11130;4-Amino-3-(4-fluorophenyl)butyricacid;β-(Aminomethyl)-4-fluorobenzenepropanoicacid;Benzenepropanoicacid,β-(aminomethyl)-Chemicalbook4-fluoro-;4-Amino-3-(4-fluoro-phenyl)-butyricAcidDISCONTINUED.PleaseseeA608650.;F-Phenibut;4-Amino-3-(4-fluorophenyl)butanoicacid
Description:
CGP 11130: A Potential Therapeutic Agent for Neurological Disorders
CGP 11130 is a novel compound that has shown promise as a potential therapeutic agent for various neurological disorders. It belongs to a class of drugs known as selective adenosine A1 receptor antagonists, which have been studied for their ability to modulate neurotransmitter activity in the brain. CGP 11130 stands out for its unique pharmacological profile and potential therapeutic applications.
One of the key properties of CGP 11130 is its ability to block adenosine A1 receptors in the brain. Adenosine is a neurotransmitter that plays a crucial role in regulating neuronal activity and maintaining the balance between excitatory and inhibitory signals. By selectively antagonizing the adenosine A1 receptors, CGP 11130 can modulate neurotransmission and potentially alleviate symptoms associated with neurological disorders.
Research has shown that CGP 11130 may have neuroprotective effects. It has been studied in animal models of neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease. In these studies, CGP 11130 has demonstrated the ability to protect neurons from damage and improve cognitive function. These findings suggest that CGP 11130 may have potential applications in the treatment of neurodegenerative disorders.
Furthermore, CGP 11130 has been investigated for its potential in managing epilepsy. Epilepsy is a neurological disorder characterized by recurrent seizures, and adenosine has been implicated in its regulation. By blocking adenosine A1 receptors, CGP 11130 may modulate the excitability of neurons and reduce the occurrence of seizures. Preliminary studies have shown promising results, although further research is needed to fully understand its efficacy and safety in epilepsy management.
CGP 11130 has also been studied for its potential in pain management. Adenosine receptors have been implicated in the modulation of pain signals in the central nervous system. By antagonizing adenosine A1 receptors, CGP 11130 may have analgesic effects and provide relief from chronic pain. However, more research is needed to determine its effectiveness and safety in this regard.
It is important to note that CGP 11130 is still in the early stages of development, and more research is needed to fully understand its therapeutic potential and safety profile. While initial studies have shown promising results, further preclinical and clinical trials are required to validate its efficacy and determine optimal dosing and administration.
In conclusion, CGP 11130 shows promise as a potential therapeutic agent for various neurological disorders. Its ability to selectively block adenosine A1 receptors and modulate neurotransmission makes it an intriguing compound for the management of neurodegenerative diseases, epilepsy, and chronic pain. However, further research is needed to fully understand its therapeutic potential and ensure its safety.
Advantage:
Hubei Langyou International Trading Co., Ltd is a renowned pharmaceutical manufacturer. We can offer high-quality products at competitive prices in quick delivery with 100% CUSTOMS PASS GUARANTEED. Never stop striving to offer our best service is our philosophy. We have Flexible and Untraceable payment terms. As a leading manufacture, our products have been exported to Germany, Norway, Poland, Finland, Spain, UK, France, Russia, the USA, Brazil, Mexico, Australia, Japan, Korea, Thailand, Indonesia, Uruguay, and many other countries.
1. Quality: Every batch of our products has to be tested by our QC(quality control) before they are allowed to sell.
2. Delivery: Stock is available, so we can deliver quickly on the very day when receiving the payment. Within 24 hours after receiving the payment and Lead time is 4 or 7 days.
3. Package: Safely and Professionally Disguised Package Guaranteed. For your safety and to insure delivery, all products will be packed in a discreet way to prevent any suspicions, no products-related name will appear on the parcels and have high successful delivery rate
4. Warm After-Sale Service: Any questions, feel free to contact us at any time, we will make a prompt response as soon as possible.
Best Seller Products:
CAS 30123-17-2 Tianeptine Sodium Salt
CAS 66981-73-5 Tianeptine
CAS 90212-80-9 CRL-40,941
CAS 385769-84-6 Amino Tadalafil
CAS 171596-29-5 Tadalafil
CAS 330784-47-9 Avanafil
CAS 224785-90-4 Vardenafil
CAS 148553-50-8 Pregabalin
CAS 68497-62-1 Pramiracetam
CAS 110958-19-5 Fasoracetam
CAS 72432-10-1 Aniracetam
CAS 77191-36-7 Nefiracetam
CAS 135463-81-9 Coluracetam
CAS 62613-82-5 Oxiracetam
CAS 77472-71-0 Phenylpiracetam Hydrazide
CAS 314728-85-3 Sunifiram
CAS 56786-63-1 5-alpha-Hydroxy- Laxogenin
CAS 7791-07-3 Sodium Perchlorate Monohydrate
CAS 1890208-58-8 Compound 7P
CAS 138112-76-2 Agomelatine
CAS 10102-18-8 Sodium Selenite
CAS 862189-95-5 Linezolid
CAS 38183-03-8 7,8-Dihydroxyflavone
CAS 1143-70-0 Urolithin A
CAS 55237-19-1 4F-Phenibut
CAS 334-50-9 Spermidine trihydrochloride
CAS 124-20-9 Spermidine
CAS 67881-98-5 2-methacryloyloxyethyl phosphorylcholine (MPC)
CAS 784-38-3 2-Amino-5-chloro-2'-fluorobenzophenone
CAS 1224690-84-9 Tianeptine hemisulfate monohydrate (THM)
Contact Info:
Email: niyoe@protonchem.cn
WhatsApp/Telegram: 86-17720330692
Threema ID: DA4UTK6D
Basic Info:
Product: CGP 11130
CAS: 52237-19-1
Form: White Powder
Purity: 99%
MF: C10H12FNO2
MW: 197.21
Package: 1-2kg/Aluminum Foil Bag, 25kg/Drum Factory supply
Sample: Available (Freight need to be paid）
Production Capacity: 200kg/Month
Payment Terms: 100% T/T, Western Union, Money Gram, Bitcoin, Tether, Monero, Bank Transfer
Delivery Time: Ship out immediately once receiving Payment
Note: Guarantee Customs
Synonyms: CGP11130;4-Amino-3-(4-fluorophenyl)butyricacid;β-(Aminomethyl)-4-fluorobenzenepropanoicacid;Benzenepropanoicacid,β-(aminomethyl)-Chemicalbook4-fluoro-;4-Amino-3-(4-fluoro-phenyl)-butyricAcidDISCONTINUED.PleaseseeA608650.;F-Phenibut;4-Amino-3-(4-fluorophenyl)butanoicacid
Description:
CGP 11130: A Potential Therapeutic Agent for Neurological Disorders
CGP 11130 is a novel compound that has shown promise as a potential therapeutic agent for various neurological disorders. It belongs to a class of drugs known as selective adenosine A1 receptor antagonists, which have been studied for their ability to modulate neurotransmitter activity in the brain. CGP 11130 stands out for its unique pharmacological profile and potential therapeutic applications.
One of the key properties of CGP 11130 is its ability to block adenosine A1 receptors in the brain. Adenosine is a neurotransmitter that plays a crucial role in regulating neuronal activity and maintaining the balance between excitatory and inhibitory signals. By selectively antagonizing the adenosine A1 receptors, CGP 11130 can modulate neurotransmission and potentially alleviate symptoms associated with neurological disorders.
Research has shown that CGP 11130 may have neuroprotective effects. It has been studied in animal models of neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease. In these studies, CGP 11130 has demonstrated the ability to protect neurons from damage and improve cognitive function. These findings suggest that CGP 11130 may have potential applications in the treatment of neurodegenerative disorders.
Furthermore, CGP 11130 has been investigated for its potential in managing epilepsy. Epilepsy is a neurological disorder characterized by recurrent seizures, and adenosine has been implicated in its regulation. By blocking adenosine A1 receptors, CGP 11130 may modulate the excitability of neurons and reduce the occurrence of seizures. Preliminary studies have shown promising results, although further research is needed to fully understand its efficacy and safety in epilepsy management.
CGP 11130 has also been studied for its potential in pain management. Adenosine receptors have been implicated in the modulation of pain signals in the central nervous system. By antagonizing adenosine A1 receptors, CGP 11130 may have analgesic effects and provide relief from chronic pain. However, more research is needed to determine its effectiveness and safety in this regard.
It is important to note that CGP 11130 is still in the early stages of development, and more research is needed to fully understand its therapeutic potential and safety profile. While initial studies have shown promising results, further preclinical and clinical trials are required to validate its efficacy and determine optimal dosing and administration.
In conclusion, CGP 11130 shows promise as a potential therapeutic agent for various neurological disorders. Its ability to selectively block adenosine A1 receptors and modulate neurotransmission makes it an intriguing compound for the management of neurodegenerative diseases, epilepsy, and chronic pain. However, further research is needed to fully understand its therapeutic potential and ensure its safety.
Advantage:
Hubei Langyou International Trading Co., Ltd is a renowned pharmaceutical manufacturer. We can offer high-quality products at competitive prices in quick delivery with 100% CUSTOMS PASS GUARANTEED. Never stop striving to offer our best service is our philosophy. We have Flexible and Untraceable payment terms. As a leading manufacture, our products have been exported to Germany, Norway, Poland, Finland, Spain, UK, France, Russia, the USA, Brazil, Mexico, Australia, Japan, Korea, Thailand, Indonesia, Uruguay, and many other countries.
1. Quality: Every batch of our products has to be tested by our QC(quality control) before they are allowed to sell.
2. Delivery: Stock is available, so we can deliver quickly on the very day when receiving the payment. Within 24 hours after receiving the payment and Lead time is 4 or 7 days.
3. Package: Safely and Professionally Disguised Package Guaranteed. For your safety and to insure delivery, all products will be packed in a discreet way to prevent any suspicions, no products-related name will appear on the parcels and have high successful delivery rate
4. Warm After-Sale Service: Any questions, feel free to contact us at any time, we will make a prompt response as soon as possible.
Best Seller Products:
CAS 30123-17-2 Tianeptine Sodium Salt
CAS 66981-73-5 Tianeptine
CAS 90212-80-9 CRL-40,941
CAS 385769-84-6 Amino Tadalafil
CAS 171596-29-5 Tadalafil
CAS 330784-47-9 Avanafil
CAS 224785-90-4 Vardenafil
CAS 148553-50-8 Pregabalin
CAS 68497-62-1 Pramiracetam
CAS 110958-19-5 Fasoracetam
CAS 72432-10-1 Aniracetam
CAS 77191-36-7 Nefiracetam
CAS 135463-81-9 Coluracetam
CAS 62613-82-5 Oxiracetam
CAS 77472-71-0 Phenylpiracetam Hydrazide
CAS 314728-85-3 Sunifiram
CAS 56786-63-1 5-alpha-Hydroxy- Laxogenin
CAS 7791-07-3 Sodium Perchlorate Monohydrate
CAS 1890208-58-8 Compound 7P
CAS 138112-76-2 Agomelatine
CAS 10102-18-8 Sodium Selenite
CAS 862189-95-5 Linezolid
CAS 38183-03-8 7,8-Dihydroxyflavone
CAS 1143-70-0 Urolithin A
CAS 55237-19-1 4F-Phenibut
CAS 334-50-9 Spermidine trihydrochloride
CAS 124-20-9 Spermidine
CAS 67881-98-5 2-methacryloyloxyethyl phosphorylcholine (MPC)
CAS 784-38-3 2-Amino-5-chloro-2'-fluorobenzophenone
CAS 1224690-84-9 Tianeptine hemisulfate monohydrate (THM)
Contact Info:
Email: niyoe@protonchem.cn
WhatsApp/Telegram: 86-17720330692
Threema ID: DA4UTK6D
